Through a five - year National Eye Institute R01 grant totaling more than $ 2.6 million, they will investigate several aspects of how EDN induces neurodegeneration and cell death and how these mechanisms might be targeted therapeutically for early disease
prevention, before
nerve damage and cell death has occurred.